Multilingual International Publishing Platform for Humanities and Social Sciences111
Volume 51 · Issue 02 · 2015
Multilingual International Publishing Platform for Humanities and Social Sciences111
In the last 5 years, great achievements have been made in glaucoma clinics and research field in China. The main Chinese glaucoma research progresses were selected by Chinese Ophthalmology Society. Among them, some research works have reached the international level. But we should clearly realize that Chinese glaucoma research work has a long way to go and the development plan should be made carefully. In the future, we need to establish the national clinical standards of glaucoma diagnosis and treatment to improve the research level, so as to enhance our international influence in glaucoma field.(Chin J Ophthalmol, 2015, 51: 81-83)
Evidence-based medicine (EBM) has markedly promoted the development of ophthalmology. Glaucoma clinical trials have been developed rapidly. Clinical trial papers have been tremendously increasing in the decade, but unhealthy tendency deviating from the nature of EBM---"conscientious, explicit and judicious" has come into notice by the medical society. It is the time to develop patient based medicine, combining with experience-based, experiment-based, ethics-based, economy-based medicine. Only face up to the fundamental problems can we avoid misleading clinicians and provide better health care of affordable, accessible, accountable medical service for patients. This is the intrinsic value of evidence-based medicine.(Chin J Ophthalmol, 2015, 51: 84-85)
Primary angle-closure glaucoma (PACG) is the main form of glaucoma in China. The pathological mechanism of PACG is not yet well understood. Traditional anatomic disorders are characterized by biometric factors such as shallow anterior chamber depth, narrow anterior chamber angle, short axial length, and thick crystalline lens. Newly found potential risk factors include dynamic changes of iris and choroid. With the development of enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT) and swept source OCT (SS-OCT), it is possible to measure choroidal thickness accurately. Several studies have found the choroid of PACG eyes was thicker than that of primary open-angle glaucoma (POAG) and normal subject eyes, which suggests that increased choroidal thickness might be another risk factor for PACG.(Chin J Ophthalmol, 2015, 51: 86-88)
Due to the different goals of current glaucoma treatments, various treatment methods have their pros and cons. Therefore, their applications are affected by factors inside and outside medical category, thus prone to a series of problems. In clinical practice, in addition to following the related clinical guidelines and standards, medical ethics problems must be considered. And besides, based on the principles of nonmaleficence, beneficence, respect and justice in medical ethics, the treatments should be carefully selected to weigh the advantages and disadvantages to the patients. Only in this way, the efficacy and safety of glaucoma treatment can be improved, and the medical and social missions of glaucoma specialists can be more reasonably completed.(Chin J Ophthalmol, 2015, 51: 89-91)
The patient was a 75-year-old male. On July 16, 2013, he went to the Department of Ophthalmology of Peking University People's Hospital for treatment due to intermittent eye swelling in his right eye for nearly 1 year and poor intraocular pressure control with two intraocular pressure lowering drugs. One year ago, the patient developed intermittent eye swelling in his right eye 1 month after cataract surgery, without nausea and vomiting. The ophthalmology examination of Peking University People's Hospital showed that the intraocular pressure of his right eye was 27 mmHg (1 mmHg =0.133 kPa), the cornea was clear, and there were a few pigmented retrocorneal deposits, but no abnormalities were found. Carteolol hydrochloride eye drops were given to the right eye twice a day, and tobramycin and dexamethasone eye drops (medication after cataract surgery) were stopped. After regular follow-up visits, the intraocular pressure fluctuated between 25 and 30 mmHg, so the patient was treated with selective laser trabeculoplasty in his right eye 10 months ago. After multiple follow-up visits, the intraocular pressure fluctuated between 25 and 40 mmHg, during which 2 or 3 kinds of intraocular pressure lowering drugs (carteolol hydrochloride eye drops, levobunolol hydrochloride eye drops, brinzolamide eye drops) were used. In 2002, the patient underwent YAG laser peripheral iridotomy due to angle-closure glaucoma in both eyes. No intraocular pressure lowering drugs were used in both eyes after operation, and the intraocular pressure was normal after regular reexamination. From December 2010 to May 2012, the intraocular pressure was 19-22 mmHg after multiple reexaminations. The cornea was clear, the anterior chamber was not shallow, the peripheral iris laser incision was unobstructed, the lens was NC2, the fundus optic papilla boundary was clear and positive after mydriasis, the optic cup was shallow, the cup-to-disc ratio was 0.5-0.6, the disc edge was normal, the retina was leopard-shaped, and the visual field examination showed no glaucoma-specific changes. On June 28 and July 12, 2012, phacoemulsification and IOL implantation were performed in the left and right eyes under local anesthesia (AcrySoft IQ IOL, 22.50 D and 22.00 D, respectively). The left eye went smoothly intraoperatively; After implantation of IOL in the right eye, the posterior capsule ruptured when viscoelastic was injected. Continuous annular capsulorhexis of the posterior capsule was performed. IOL was implanted in the ciliary sulcus. The operation was smooth, and no mydriatic drug was used after the operation. After operation, the left eye recovered smoothly, and the intraocular pressure was maintained at about 13 mmHg. The condition of the right eye is described above.
The patient was a 19-year-old female. On March 7, 2008, I came to the Department of Ophthalmology of Jinan Second People's Hospital for treatment due to the protrusion of my left eyeball since childhood, which gradually aggravated for 3 years. General examination: Scattered irregular coffee spot-like changes (>6 places) on the whole body skin with a diameter of 0.5~6.0 cm, and scoliosis deformity (
The patient was a female, 45 years old. On February 22, 2010, he came to Tianjin Medical University Eye Hospital for treatment due to swelling and tearing in his right eye for 3 years, aggravated eyelid swelling, ptosis, and headache on the right side for 4 months. MRI examination showed a tumor above the right orbit. After treatment with 40 mg of prednisone acetate, the appearance of both eyes was consistent. After the dose of prednisone acetate was reduced to 5 mg, the condition recurred, so he was admitted to the hospital with "right orbital mass". The patient denied previous history of ophthalmic disease, systemic disease, and family disease. Admission physical examination: general condition is good. The visual acuity was 0.8 in the right eye and 1.0 in the left eye. The upper eyelid of the right eye is swollen and slightly drooping, the eyelid margin is located above the pupil margin, and the lifting is slightly limited. The cornea was clear, the anterior chamber was clear, the lens was clear, and no obvious abnormalities were found in the fundus. The eyeball is prominent and displaced downward. Exophthalmia: 16 mm in the right eye, 14 mm in the left eye and 105 mm in the orbital distance. Eye movement: Upward rotation was limited, and no abnormalities were observed in the eye movement in all directions. IOP 15.6 mmHg. Palpation: Flat hard mass can be palpable at the upper orbital margin, the surface is not smooth, pushed immobile, orbital pressure (+ +), and no mass is palpable around the orbit. The anterior segment and fundus of the left eye were roughly normal. Cervical lymph nodes were unpalpable. B-mode ultrasound showed that the hypoechoic area above the right external orbit was flat, with clear boundaries and uneven internal echoes. Color Doppler flow imaging showed that the blood flow signal in the tumor was rich, with thick strip-like blood flow signal, staghorn-like bifurcation at the front end, and blue area in the red blood flow signal (
The child was a 3-year-old male. Due to the discovery of left orbital mass since childhood, there was no obvious change in the mass within 3 years, and he went to the Department of Ophthalmology of Peking University Third Hospital on June 2, 2012. The child had no other symptoms of general discomfort. Family history and genetic history are unknown. Ophthalmic examination: Binocular visual acuity examination did not cooperate, and no obvious abnormality was found in the right eye. The left eye is incomplete closure, the left upper eyelid is everted, the bulbar conjunctiva is obviously congested and edema, and an ellipsoidal mass is visible in the eye socket. The mass protrudes from the orbit, is tough to touch, has no adhesion to the surrounding tissues, and the structure of the eyeball is invisible (
Although the pathogenesis of glaucoma is complicated and multifactorial, elevated intraocular pressure (IOP) remains the most important known risk factor. The higher the IOP and the larger the IOP fluctuation, the more damage to the optic nerve. IOP fluctuation can be affected by many factors, such as emotion, exercise and circadian rhythm, etc. Recently, the effects of postural change on IOP fluctuation are receiving more and more attention. This article reviews the effects of different body positions on IOP fluctuation, the effects of surgery, medications and aging on posture-induced IOP fluctuation and the effects of postural change on IOP fluctuation of certain special groups. The possible mechanisms of posture-induced IOP fluctuation are also discussed in this article.(Chin J Ophthalmol, 2015, 51: 146-150)
Macular edema represents a major cause of visual loss in uveitis and its adequate management is crucial for the maintenance of useful vision in patients with uveitis. Corticosteroid is the first choice for UME treatment. Long term and sustained release implantation is the newest administration for medical therapy. The immunosuppressant such as cyclosporine, methotrexate, azathioprine and mycophenolate mofetil can be used specially for chronic and intractable UME. Moreover, these years, some newly developed biological agents, for example, anti-VEGF, interferon-α, anti-TNF and acetazolamide will provide new options for UME pharmacotherapy.(Chin J Ophthalmol, 2015, 51: 151-154)
Incomplete perifoveal posterior vitreous detachment (PVD) associated with abnormal vitreomacular adhesion (VMA) can cause vitreomacular traction (VMT) and macular hole (MH) formation, which require vitrectomy treatment. Pharmacologic vitreolysis, which is intravitreal injection with vitreolytic enzymes to resolve VMA, may be used as an alternative therapy. Ocriplasmin, formerly known as microplasmin, is a recombinant truncated form of plasmin with proteolytic activity against fibronectin and laminin. It was recently approved for VMA treatment in the European Union and USA. Phase Ⅲ studies indicated that ocriplasmin injection was a safe and effective treatment for selected cases of symptomatic VMA and MH. VMA release was achieved in 26.5% of ocriplasmin-injected eyes versus 10.1% of the placebo group. MH closure was achieved in 40.6% as compared with 10.6% of the placebo group. In comparison with the outcome after vitrectomy, the success rate of ocriplasmin was still far below expectation. Ocular adverse events included vitreous floaters, photopsia and profound visual decline. Its efficacy and safety need to be further evaluated in more clinical trials.(Chin J Ophthalmol, 2015, 51: 155-160)
CURRENT ISSUE


